Sodium carboxymethyl starch can be used as pharmaceutical excipients, body immune organ improvement solution, and thickening agent in food additives.
 
Facts of Sodium carboxymethyl starch

Sodium carboxymethyl starch (CMS or SCMS) is a starch ether derivative derived from starch. It is soluble in water at room temperature and forms a transparent to light milky and viscous solution. Its synonyms are Carboxymethyl Starch Sodium Salt, Sodium Starch Glycolate, Carboxymethyl Starch Sodium, CMS-Na, Na-CMS, Sodium CMS, Modified Starch, Anionic Carboxy Methyl Starch, Anionic Modified Starch, Starch Gum, CMS, Carboxy Methyl Ethers of Starch. Its CAS Number is 9063-38-1.

 
Sodium carboxymethyl starch as pharmaceutical excipients

Sodium starch glycolate is widely used in oral pharmaceuticals as a disintegrant in capsule and tablet formulations. It is recommended to use in tablets prepared by either directcompression or wet-granulation processes. The dosage is usually 2% to 8% in tablets. Although 2% is sufficient in many cases, the optimal content is 4%. Carboxymethyl sodium can also be used as a suspending agent.

Sodium carboxymethyl starch solution to increase body immune organ

Sodium carboxymethyl starch can increase the body's immune organs (thymus), increase the number of cells; selectively stimulate T cells, promote T cell maturation and differentiation; promote lymphoblast transformation, increase the absolute lymphocyte count; increase plasma IgA, IgG concentrations To improve the body's immunity, reduce the number and duration of repeated upper respiratory tract infections in children, reduce the harm to the health and growth of children, and also reduce the content of IgM in plasma; reduce the content of basophils and reduce basophils The combination of cell surface receptors and IgE produces an allergic response related to the onset of asthma, thereby reducing bronchial asthma induced by repeated upper respiratory infections in children. Therefore, carboxymethyl starch solution is an immune stimulant, which can stimulate the activity of immune cells, increase antibody levels, and increase resistance.

Sodium carboxymethyl starch as thickening agent in food additives

There are about 30 kinds of thickeners in food additives, they can give foods a thick and suitable mouth feel. The most common of these thickeners are modified starches and gums, such as sodium carboxymethyl starch, hydroxypropyl starch, guar gum, xanthan gum, pectin, gelatin and the like. Thickeners are generally very safe, so there is no limit to their use in many foods.

Sodium carboxymethyl starch supplier

Shandong Liaocheng Luxi Yaofu Co., Ltd. Is a factory in China specializing in producing sodium carboxymethyl starch as pharmaceutical excipients. The results are in compliance. Shandong Liaocheng Luxi Yaofu Co., Ltd. was established in 2005. The new site is located in the Houlou Industrial Park in Jiazhai Town, Luanping County, Liaocheng City with convenient transportation taking up 50 mu of land with total floor area of 148,000 square meters. Business scope: production and management of pharmaceutical excipients. The company's main products: dextrin, microcrystalline cellulose, sodium carboxymethyl starch. The product of the company is tested according to GB 29937-2013 "Food Safety National Standard Food Additive Carboxymethyl Starch Sodium".
 

Related news in pharmaceutical industry: 

New lymphoma drug! Roche's first CD79b target ADC drug Polivy qualified as orphan drug to treat DLB.
The newly revised Drug Administration Law of China to take effect on December 1, 2019 for better regulation of drug production
2019 China Vitamin C Export, Market Structure and Prospect Introduction
Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa
Health Highlights: Nov. 18, 2019
£373k awarded to earlier pancreatic cancer diagnosis research
The newly revised Drug Administration Law of China to take effect on December 1, 2019 for better regulation of drug production
Industry of Vitamin A: Supply Decrease and Market Demand Increase in Short Term
Export of China's nutrition and health products in the first half of 2019
FDA: Biotin Supplements Could Affect Results of Medical Tests
CPhI Annual Report predicts Europe to surpass the USA in biologic manufacturing capacity by 2023
FDA approves first therapy to treat patients with rare blood disorder
Protein could offer therapeutic target for pancreatic cancer